Thrombin, a serine protease playing
a central role in the coagulation
cascade reactions and a potent neurotoxin produced by injured brain
endothelial cells, is a recognized cardiac biomarker and a critical
biomarker for Alzheimer’s disease development. Both in vivo
and in vitro, its low physiological concentrations and nonspecific
binding of other components of physiological fluids complicate electroanalysis
of thrombin. Here, femtomolar levels of thrombin in serum and an artificial
cerebrospinal fluid (CSF) were detected by the indicator-free electrochemical
methodology exploiting the O2 reduction reaction directly,
with no electron transfer mediators, electrocatalyzed by the covalent
G4-hemin DNAzyme complex naturally self-assembling upon thrombin binding
to the hemin-modified 29-mer DNA aptamer sequence tethered to gold
via an alkanethiol linker. Coadsorbed PEG inhibited nonspecific protein
binding and allowed the sought signal resolution. The proposed assay
exploiting the “oxidase” activity of G4-hemin DNAzyme
does not require any coreactants necessary for the traditional peroxidase
activity-based assays with this DNAzyme, such as H2O2 and redox mediators, or solution deaeration and allows fast,
overall 30 min analysis of thrombin in aerated buffer, CSF, and 1%
human serum solutions. This pioneer approach exploiting the oxidase
activity G4-hemin DNAzyme is simple, sensitive, and selective and
represents a new tool for ultrasensitive electrocatalytic assays based
on simple and efficient O2-dependent DNAzyme labels.